Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26217685 | 0.85 | CA2 (0.50) | ALDH1A1GAAGFERCA2CA1 | |
| SCHEMBL26217682 | 0.85 | CA2 (0.52) | ALDH1A1GAAGFERCA2CA1 | |
| SCHEMBL26217730 | 0.79 | CA2 (0.43) | ALDH1A1GAACA2CA1PTGS1 | |
| SCHEMBL55691 | 0.79 | MAPK1 (0.54) | ALDH1A1CA2CA1PTGS1PTGS2 | |
| SCHEMBL8537382 | 0.79 | MAPK1 (0.54) | ALDH1A1CA2CA1PTGS1PTGS2 | |
| Potassium SCHEMBL29827207 | 0.78 | MAPK1 (0.53) | ALDH1A1CA2CA1PTGS1PTGS2 | |
| SCHEMBL26217695 | 0.77 | CA2 (0.44) | CA2CA1PTGS1PTGS2MAPK1 | |
| SCHEMBL10933116 | 0.77 | ALDH1A1 (0.43) | ALDH1A1GAACA2CA1PTGS1 | |
| SCHEMBL10628416 | 0.77 | CA2 (0.44) | CA2CA1PTGS1PTGS2PTPN11 | |
| SCHEMBL10680491 | 0.76 | GPR35 (0.41) | CA2CA1PTGS1PTGS2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230278972-A1 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | FMC CORPORATION | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278972-A1 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | CBR3, CBR1, GRHPR | ALDH1A1 1354/4885GAA 1675/4885GFER 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.